ACHL (@achlcme) 's Twitter Profile
ACHL

@achlcme

The Academy for Continued Healthcare Learning provides relevant education to enhance healthcare delivery and patient outcomes.

ID: 4009688219

linkhttp://www.achlcme.org/ calendar_today21-10-2015 13:26:43

2,2K Tweet

717 Followers

2,2K Following

ACHL (@achlcme) 's Twitter Profile Photo

Identify, or enhance your knowledge of risk factors, common symptoms, and how symptoms change over time in this customized educational experience. Visit manage-eoe.org #EoE #GI #ACHLCustomED

Identify, or enhance your knowledge of risk factors, common symptoms, and how symptoms change over time in this customized educational experience. 

Visit manage-eoe.org

#EoE #GI #ACHLCustomED
ACHL (@achlcme) 's Twitter Profile Photo

Expiring Soon! Learn how to develop strategies to mitigate challenges and barriers to optimizing RET testing for patients with NSCLC and thyroid cancer. bit.ly/3xVQa9w

Expiring Soon!
Learn how to develop strategies to mitigate challenges and barriers to optimizing RET testing for patients with NSCLC and thyroid cancer.
bit.ly/3xVQa9w
ACHL (@achlcme) 's Twitter Profile Photo

Learn more about the therapeutic potential of emerging neurokinin receptor antagonists in managing VMS for women with autoimmune conditions. bit.ly/3iFDRsZ

Learn more about the therapeutic potential of emerging neurokinin receptor antagonists in managing VMS for women with autoimmune conditions.
bit.ly/3iFDRsZ
ACHL (@achlcme) 's Twitter Profile Photo

Transgender youth see higher rates of suicide, poorer health outcomes, and an overall lack of access to quality care. Learn how to ensure your gender-diverse patients are receiving the care they deserve in this expert interview: bit.ly/3PKrDM6

Transgender youth see higher rates of suicide, poorer health outcomes, and an overall lack of access to quality care. 
Learn how to ensure your gender-diverse patients are receiving the care they deserve in this expert interview: bit.ly/3PKrDM6
ACHL (@achlcme) 's Twitter Profile Photo

Do you do cognitive, imaging, and/or biomarker tests when you suspect Alzheimer's disease (AD)? In this innovative “cinemeducation” format, you will see representative interactions that model best practices. youtu.be/EtI8UN6TeCA

ACHL (@achlcme) 's Twitter Profile Photo

▶️ NEW ACTIVITY ALERT ◀️ How do you navigate the growing number of treatments for multiple sclerosis? What is the best approach for treatment naïve MS patients? When is the best time to initiate high-efficacy DMTs? ow.ly/O3EE50MA7fa

▶️ NEW ACTIVITY ALERT ◀️

How do you navigate the growing number of treatments for multiple sclerosis? What is the best approach for treatment naïve MS patients?  When is the best time to initiate high-efficacy DMTs?

ow.ly/O3EE50MA7fa
ACHL (@achlcme) 's Twitter Profile Photo

Listen as experts discuss the emerging potential of microbiota restoration therapies for patients with recurrent C. difficile infections. bit.ly/3urKRMu

Listen as experts discuss the emerging potential of microbiota restoration therapies for patients with recurrent C. difficile infections.
bit.ly/3urKRMu
ACHL (@achlcme) 's Twitter Profile Photo

Learn how to incorporate strategies and tools to mitigate and manage veno-occlusive disease (VOD) risk in patients with R/R ALL proceeding to HSCT vodrisk.org #hematology #oncology

Learn how to incorporate strategies and tools to mitigate and manage veno-occlusive disease (VOD) risk in patients with R/R ALL proceeding to HSCT
vodrisk.org
#hematology #oncology
ACHL (@achlcme) 's Twitter Profile Photo

In this symposia highlight, Dr. Sripal Bangalore, Dr. John Flack, and Dr. Sandra Taler discuss emerging therapies for resistant hypertension. Access them today. bit.ly/3h5iT64

In this symposia highlight, Dr. Sripal Bangalore, Dr. John Flack, and Dr. Sandra Taler discuss emerging therapies for resistant hypertension. Access them today.
bit.ly/3h5iT64
ACHL (@achlcme) 's Twitter Profile Photo

Did you know that 40% of #Cdiff infections are community-acquired? Learn more in is downloadable toolkit: ow.ly/ocwN50MybVv

Did you know that 40% of #Cdiff infections are community-acquired? 
Learn more in is downloadable toolkit: ow.ly/ocwN50MybVv
ACHL (@achlcme) 's Twitter Profile Photo

Why is an earlier diagnosis of #AlzheimersDisease so important? Access this downloadable PDF tool to help you navigate this with your patients and caregivers. ow.ly/AmQS50M8qOs For additional information, visit diagnose-alz.org

Why is an earlier diagnosis of #AlzheimersDisease so important? 
Access this downloadable PDF tool to help you navigate this with your patients and caregivers.
ow.ly/AmQS50M8qOs

For additional information, visit diagnose-alz.org
ACHL (@achlcme) 's Twitter Profile Photo

This NEW self-directed education was designed for diverse members of the interdisciplinary care team that treat or may encounter patients with R/R ALL who are at risk for VOD. Access today at vodrisk.org #oncology

This NEW self-directed education was designed for diverse members of the interdisciplinary care team that treat or may encounter patients with R/R ALL who are at risk for VOD.
Access today at vodrisk.org 

#oncology
ACHL (@achlcme) 's Twitter Profile Photo

Are you current with the recent data and guidance on influenza vaccine selection based on age, risk factors, and individual characteristics? youtu.be/F27kCepKrNw

ACHL (@achlcme) 's Twitter Profile Photo

This activity is for #gastroenterologists, #allergists, #immunologists and #dieticians. Explore how it can help you and your patients today: manage-eoe.org

This activity is for #gastroenterologists, #allergists, #immunologists and #dieticians. 

Explore how it can help you and your patients today: manage-eoe.org
ACHL (@achlcme) 's Twitter Profile Photo

What every clinician needs to know about diagnosing and treating women with iron-deficient anemia. youtu.be/RwQ6AwC0I2w

ACHL (@achlcme) 's Twitter Profile Photo

Are you ready to incorporate these emerging therapies into your treatment plans? ow.ly/A9Rg50Myfhc #hematology #oncology

Are you ready to incorporate these emerging therapies into your treatment plans? 
ow.ly/A9Rg50Myfhc

#hematology #oncology
ACHL (@achlcme) 's Twitter Profile Photo

Listen in as the experts discuss the therapeutic potential of emerging neurokinin receptor antagonists in managing VMS for women with autoimmune conditions. bit.ly/3iFDRsZ

Listen in as the experts discuss the therapeutic potential of emerging neurokinin receptor antagonists in managing VMS for women with autoimmune conditions.
bit.ly/3iFDRsZ
ACHL (@achlcme) 's Twitter Profile Photo

Learn how to apply evidence-based strategies for DMT selection and monitoring treatment response to optimize personalized management in patients with #MS. ow.ly/RSxw50MA7AA

Learn how to apply evidence-based strategies for DMT selection and monitoring treatment response to optimize personalized management in patients with #MS.
ow.ly/RSxw50MA7AA
ACHL (@achlcme) 's Twitter Profile Photo

Is 63 too young for a diagnosis of #AlzheimersDisease? Learn more in this education designed for #primarycare diagnose-alz.org diagnose-alz.org